Identification of Endocannabinoids and Cannabinoid CB1 Receptor mRNA in the Pituitary Gland

Publisher： Karger

E-ISSN： 1423-0194|70|2|137-145

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.70, Iss.2, 1999-08, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Endogenous Cannabinoid, Anandamide, Activates the Hypothalamo-Pituitary-Adrenal Axis in CB1 Cannabinoid Receptor Knockout Mice

By  

Neuroendocrinology, Vol. 78, Iss. 6, 2003-12 ,pp. : 294-300

Karger

Access to resources Recommend Favorite

Developmentally and Regionally Regulated Expression of Growth Hormone Secretagogue Receptor mRNA in Rat Brain and Pituitary Gland

By  

Neuroendocrinology, Vol. 72, Iss. 6, 2000-12 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Hexarelin Modulates the Expression of Growth Hormone Secretagogue Receptor Type 1a mRNA at Hypothalamic and Pituitary Sites

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 52-59

Karger

Access to resources Recommend Favorite

Role of Glucocorticoids in the Regulation of Pituitary Somatostatin Receptor Subtype (sst1–sst5) mRNA Levels: Evidence for Direct and Somatostatin-Mediated Effects

By  

Neuroendocrinology, Vol. 78, Iss. 3, 2003-10 ,pp. : 163-175

Karger

Access to resources Recommend Favorite

Peripheral Metabolic Effects of Endocannabinoids and Cannabinoid Receptor Blockade

By  

Obesity Facts, Vol. 1, Iss. 1, 2008-02 ,pp. : 8-15

Karger

Access to resources Recommend Favorite